Xiaobin Ma
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Pharmacology top 10%
- Inflammatory mediators and NSAID effects
- Flavonoids in Medical Research
Papers in
-
- DNA Repair Mechanisms 4
- Epigenetics and DNA Methylation 4
- Circular RNAs in diseases 4
- Oncology 13
- Cancer-related Molecular Pathways 4
- PARP inhibition in cancer therapy 4
- Co-authors
- Xi-Jing Wang (30 shared papers)Huafeng Kang (35 shared papers)Shuai Lin (25 shared papers)Weili Min (9 shared papers)Peijia Wang (7 shared papers)Haitao Guan (5 shared papers)Yi Sun (3 shared papers)Jie Gao (3 shared papers)
- Journals
- Oncotarget (5 papers)Medicine (4 papers)Cancer Cell International (3 papers)Ecological Indicators (2 papers)Biochemical and Biophysical Research Communications (2 papers)
- Partner nations
- ChinaUnited StatesSouth Sudan
In The Last Decade
Xiaobin Ma
61 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 133
- Cancer Research 223
- Pharmacology 140
- Pathology and Forensic Medicine 111
- Molecular Biology 431
- Oncology 154
Countries citing papers authored by Xiaobin Ma
This map shows the geographic impact of Xiaobin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Ma more than expected).
Fields of papers citing papers by Xiaobin Ma
This network shows the impact of papers produced by Xiaobin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Ma. The network helps show where Xiaobin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 96 | |
| 2 | 2012 | 84 | |
| 3 | 2012 | 79 | |
| 4 | 2016 | 59 | |
| 5 | 2022 | 51 | |
| 6 | 2013 | 49 | |
| 7 | 2015 | 47 | |
| 8 | 2022 | 46 | |
| 9 | 2016 | 44 | |
| 10 | 2023 | 42 | |
| 11 | 2012 | 40 | |
| 12 | 2018 | 38 | |
| 13 | 2016 | 36 | |
| 14 | 2013 | 35 | |
| 15 | 2017 | 32 | |
| 16 | 2016 | 28 | |
| 17 | 2016 | 24 | |
| 18 | 2013 | 22 | |
| 19 | 2016 | 22 | |
| 20 | 2013 | 21 |
About Xiaobin Ma
Xiaobin Ma is a scholar working on Molecular Biology, Oncology, Cancer Research, Global and Planetary Change and Pharmacology, having authored 64 papers that have together received 1.3k indexed citations. Recurring topics across this work include Land Use and Ecosystem Services (6 papers), Cancer-related molecular mechanisms research (5 papers), DNA Repair Mechanisms (4 papers), Epigenetics and DNA Methylation (4 papers), Circular RNAs in diseases (4 papers), Cancer-related Molecular Pathways (4 papers), PARP inhibition in cancer therapy (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (223 citations), Pharmacology (140 citations), Pathology and Forensic Medicine (111 citations), Molecular Biology (431 citations) and Oncology (154 citations). Xiaobin Ma has collaborated with scholars based in China, United States and South Sudan. Frequent co-authors include Xi-Jing Wang, Huafeng Kang, Shuai Lin, Weili Min, Peijia Wang, Haitao Guan, Yi Sun, Jie Gao, Wenying Wu and Yan Diao. Their work appears in journals such as Oncotarget, Medicine, Cancer Cell International, Ecological Indicators and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.